
Gensulin R100 IU/ml
Beximco Pharmaceuticals Ltd.
Insulin Human [Fast-Acting] is a short-acting (regular) biosynthetic human insulin used to improve glycemic control in patients with diabetes mellitus.
Insulin Human [Fast-Acting] is a short-acting (regular) biosynthetic human insulin used to improve glycemic control in patients with diabetes mellitus.
Use of Insulin Human [Fast-Acting] always requires individualized dosing based on blood glucose monitoring under a physician's supervision.
Dosage of Insulin Human [Fast-Acting] must be individualized by the treating physician based on blood glucose monitoring, metabolic needs, meal pattern, and activity level. It is not to be self-adjusted by the patient without medical guidance.
| Indication | Typical approach |
|---|---|
| Type 1 diabetes mellitus | Given subcutaneously as part of a multiple daily injection regimen, combined with an intermediate- or long-acting insulin; dose individualized by physician. |
| Type 2 diabetes mellitus | Individualized subcutaneous dosing, alone or combined with oral antidiabetic agents/other insulins, as directed by physician. |
| Diabetic ketoacidosis / hyperosmolar state | Given intravenously (as infusion or bolus) in a hospital setting, under close medical and laboratory monitoring; dose titrated to blood glucose response. |
| Pediatric patients | Individualized dosing with frequent blood glucose monitoring; safety and dosing require close physician supervision. |
Timing: When given subcutaneously, Insulin Human [Fast-Acting] is typically injected approximately 30 minutes before a meal to match its onset of action with the post-meal glucose rise.
Important: Insulin Human [Fast-Acting] must never be interchanged with other insulin products, brands, or concentrations unless specifically directed by a physician, as this can require a change in dose. Do not adjust the dose of Insulin Human [Fast-Acting] on your own; any change should be made only under medical supervision.
The most common and clinically important adverse reaction with Insulin Human [Fast-Acting] is hypoglycemia, which can occur with any insulin therapy.
Insulin Human [Fast-Acting] is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.